These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26502956)

  • 1. Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model.
    Xu X; Chen X; Hu H; Dailey AB; Taylor BD
    BMC Cancer; 2015 Oct; 15():806. PubMed ID: 26502956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Patterns of Testosterone Levels in Individuals and Risk of Prostate Cancer among Hypogonadal Men: A Longitudinal Study.
    Xu X; Zhang X; Zhong Y; Saad F; Perez-Patron MJ; Haider K; Haider A
    J Urol; 2018 Feb; 199(2):465-473. PubMed ID: 28941925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging.
    Pierorazio PM; Ferrucci L; Kettermann A; Longo DL; Metter EJ; Carter HB
    BJU Int; 2010 Mar; 105(6):824-9. PubMed ID: 19751256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy.
    Slater S; Oliver RT
    Drugs Aging; 2000 Dec; 17(6):431-9. PubMed ID: 11200304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
    García-Cruz E; Piqueras M; Huguet J; Peri L; Izquierdo L; Musquera M; Franco A; Alvarez-Vijande R; Ribal MJ; Alcaraz A
    BJU Int; 2012 Dec; 110(11 Pt B):E541-6. PubMed ID: 22584031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone Therapy and Prostate Cancer.
    Davidson E; Morgentaler A
    Urol Clin North Am; 2016 May; 43(2):209-16. PubMed ID: 27132578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.
    Klap J; Schmid M; Loughlin KR
    J Urol; 2015 Feb; 193(2):403-13. PubMed ID: 25260832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy.
    García-Cruz E; Carrión Puig A; García-Larrosa A; Sallent A; Castañeda-Argáiz R; Piqueras M; Ribal MJ; Leibar-Tamayo A; Romero-Otero J; Alcaraz A
    Scand J Urol; 2013 Aug; 47(4):282-9. PubMed ID: 23181478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients.
    Wang Y; Dai B; Ye DW
    Asian J Androl; 2017; 19(2):178-183. PubMed ID: 26975487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy.
    Lane BR; Stephenson AJ; Magi-Galluzzi C; Lakin MM; Klein EA
    Urology; 2008 Dec; 72(6):1240-5. PubMed ID: 18692874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new era of testosterone and prostate cancer: from physiology to clinical implications.
    Khera M; Crawford D; Morales A; Salonia A; Morgentaler A
    Eur Urol; 2014 Jan; 65(1):115-23. PubMed ID: 24011426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients.
    Porcaro AB; Migliorini F; Romano M; Petrozziello A; Antoniolli SZ; Rubilotta E; Lacola V; Sava T; Ghimenton C; Caruso B; Monaco C; Comunale L
    Int Urol Nephrol; 2010 Sep; 42(3):673-81. PubMed ID: 19902378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.
    Watts EL; Appleby PN; Perez-Cornago A; Bueno-de-Mesquita HB; Chan JM; Chen C; Cohn BA; Cook MB; Flicker L; Freedman ND; Giles GG; Giovannucci E; Gislefoss RE; Hankey GJ; Kaaks R; Knekt P; Kolonel LN; Kubo T; Le Marchand L; Luben RN; Luostarinen T; Männistö S; Metter EJ; Mikami K; Milne RL; Ozasa K; Platz EA; Quirós JR; Rissanen H; Sawada N; Stampfer M; Stanczyk FZ; Stattin P; Tamakoshi A; Tangen CM; Thompson IM; Tsilidis KK; Tsugane S; Ursin G; Vatten L; Weiss NS; Yeap BB; Allen NE; Key TJ; Travis RC
    Eur Urol; 2018 Nov; 74(5):585-594. PubMed ID: 30077399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes.
    Ory J; Flannigan R; Lundeen C; Huang JG; Pommerville P; Goldenberg SL
    J Urol; 2016 Oct; 196(4):1082-9. PubMed ID: 27131465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between serum testosterone levels and prostatic cancer].
    Rivera P; Tagle R; Mir S; González R
    Actas Urol Esp; 2003; 27(10):788-92. PubMed ID: 14735860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between total and free serum testosterone and the risk of prostate cancer and tumour aggressiveness.
    Morote J; Ramirez C; Gómez E; Planas J; Raventós CX; de Torres IM; Catalán R
    BJU Int; 2009 Aug; 104(4):486-9. PubMed ID: 19220251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P; Lumme S; Tenkanen L; Alfthan H; Jellum E; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Lehtinen M; Dillner J; Stenman UH; Hakama M
    Int J Cancer; 2004 Jan; 108(3):418-24. PubMed ID: 14648709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Testosterone and prostate].
    Vaucher L; Paduch DA; Jichlinski P; Pralong F
    Rev Med Suisse; 2011 Dec; 7(320):2399-400, 2402-3. PubMed ID: 22232869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population differences in the testosterone levels of young men are associated with prostate cancer disparities in older men.
    Calistro Alvarado L
    Am J Hum Biol; 2010; 22(4):449-55. PubMed ID: 20087895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.